Indeed, the major players exerting tumor-directed killing are thought to be the CD8+ T cells which can be either resident or attracted to the inflamed tumor microenvironment upon presentation of tumor-antigen on MHC class I molecules 4,5. The gene discussed is CD8A; the disease is neoplasm.